SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shilpa Medicare informs about disclosure

23 Jan 2025 Evaluate
Shilpa Medicare has informed that the company’s 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Teriflunomide.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

606.95 3.35 (0.56%)
31-Jul-2026 13:28 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 2044.75
Dr. Reddys Labs. 1151.30
Cipla 1474.95
Lupin 2425.80
Zydus Lifesciences 1124.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: